An overview of the heparin-induced thrombocytopenia syndrome.
about
Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremityPrimary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremityHeparin-induced thrombocytopenia: an updateHITlights: a career perspective on heparin-induced thrombocytopeniaRole of platelets in neuroinflammation: a wide-angle perspectiveNonpalpable purpura within a setting of anticoagulant therapy and metastatic carcinoma.Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options.Thrombocytopenias: a clinical point of view.The direct thrombin inhibitor argatroban: a review of its use in patients with and without HIT.Lepirudin in the management of patients with heparin-induced thrombocytopenia.Profiling of heparin-induced thrombocytopenia antibody levels in patients with and without diabetes.Have You Been HIT?Thrombocytopenia in the intensive care unit.Heparin-induced thrombocytopenia in a hemodialysis patient treated with fondaparinux: nephrologists between two fires.Antithrombotic therapy in heparin-induced thrombocytopenia: guidelines translated for the clinician.Reversible crystallization of argatroban after subcutaneous application in pigs.Fatal anaphylactoid reaction associated with heparin-induced thrombocytopenia.The clinical significance and risk factors of anti-platelet factor 4/heparin antibody on maintenance hemodialysis patients: a two-year prospective follow-up.Heparin induced thrombocytopenia: review.Heparin-induced thrombocytopaenia (HIT)-an overview: what does the nephrologist need to know and do?Stent thrombosis caused by metal allergy complicated by protein S deficiency and heparin-induced thrombocytopenia: a case report and review of the literature.Comparative Analysis of the Suspected Heparin-Induced Thrombocytopenia Level in Korea.Recurrent heparin-induced thrombocytopenia due to heparin rinsing before priming the machine in a hemodialysis patient: A case report.
P2860
Q24197472-CC64C843-D944-4CDB-B92E-34DCED0421B6Q24201769-8507DF48-25A0-4557-BB7B-CCA3471B6997Q24815767-8B4EF169-56F8-4C47-915D-00E854C5B8F5Q26828351-98FB80C1-BF72-45EA-BEE0-3D7BD8BF54CFQ28393808-EF42AD55-D615-44F5-A1A6-F129776BB2E9Q33372367-3D0CA260-F47A-41C8-9FF6-ECA60FBC0D39Q33373128-CC072A35-3C4A-4E58-844A-B8D3789DE9D3Q33384884-CC05A46A-D856-4E13-99A8-DE65331F1032Q33385970-030CE320-6FA5-4E62-9CCA-B3A1F085BB4DQ33385972-9C2720F1-0E2A-4A1E-A110-54B4EC0A86DCQ33388783-23EFAA94-C312-441A-BFBE-EDBCC66EDD5CQ33395240-4E124466-E137-4337-B2A4-6CB0D630830EQ33399094-D3D92932-8FAA-4BF0-8430-9F547FA5677DQ33401438-8488E060-ED08-4703-BBF2-F8DDCEF86DC4Q33402572-3A882968-9325-4226-8295-1319CB11F0E7Q33403381-BEFF9D25-C67D-4A14-9172-C1F02711E019Q33407023-9281D8A3-54DC-4D33-BEA2-4BE20D2064A6Q33407497-7FC578E3-BC1F-4708-99B6-245C725D0EE9Q33410083-F0961E95-A743-4903-A891-4C7F1CCC0CE3Q33423596-D872BD88-BFC6-4462-83A7-F29D938769B2Q33424704-D2062694-AD57-486B-9C71-02D056011558Q33440667-95CFFCF6-30CA-4171-AF40-3CC97AC9A820Q47267941-5F550482-369C-408E-AB3B-9BBB7AB9D70D
P2860
An overview of the heparin-induced thrombocytopenia syndrome.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
An overview of the heparin-induced thrombocytopenia syndrome.
@ast
An overview of the heparin-induced thrombocytopenia syndrome.
@en
type
label
An overview of the heparin-induced thrombocytopenia syndrome.
@ast
An overview of the heparin-induced thrombocytopenia syndrome.
@en
prefLabel
An overview of the heparin-induced thrombocytopenia syndrome.
@ast
An overview of the heparin-induced thrombocytopenia syndrome.
@en
P356
P1476
An overview of the heparin-induced thrombocytopenia syndrome.
@en
P304
P356
10.1055/S-2004-831039
P577
2004-06-01T00:00:00Z